Medtronic’s new disposable glucose sensor offers enhanced comfort and accuracy for diabetes management, now cleared for use with the MiniMed 780G insulin pump system.

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever.

The Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.

The envisioned partnership will be an evolution of the AiBLE ecosystem which integrates connected care and predictive technology to advance surgery.

SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results.

Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain.

AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy.

The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access.

This is the first and only deep brain stimulation system with sensing, directionality, and advanced programming.

With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert.